<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2022.838087</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Live-Birth Prediction of Natural-Cycle <italic>In Vitro</italic> Fertilization Using 57,558 Linked Cycle Records: A Machine Learning Perspective</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname><given-names>Yanran</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1482282"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname><given-names>Lei</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1482324"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yin</surname><given-names>Xinghui</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1481923"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname><given-names>Wenfeng</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Medical School of Nanjing University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>College of Computer and Information, Hohai University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution> Nanjing Marine Radar Institute</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Claus Yding Andersen, University of Copenhagen, Denmark</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Kannamannadiar Jayaprakasan, University of Nottingham, United Kingdom; Catello Scarica, Center for Reproductive Medicine, Italy</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Yanran Zhang, <email xlink:href="mailto:yanransyczh@163.com">yanransyczh@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Reproduction, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>838087</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhang, Shen, Yin and Chen</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhang, Shen, Yin and Chen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Natural-cycle <italic>in vitro</italic> fertilization (NC-IVF) is an <italic>in vitro</italic> fertilization (IVF) cycle without gonadotropins or any other stimulation of follicular growth. Previous studies on live-birth prediction of NC-IVF were very few; the sample size was very limited. This study aims to construct a machine learning model to predict live-birth occurrence of NC-IVF using 57,558 linked cycle records and help clinicians develop treatment strategies.</p>
</sec>
<sec>
<title>Design and Methods</title>
<p>The dataset contained 57,558 anonymized register patient records undergoing NC-IVF cycles from 2005 to 2016 filtered from 7bsp;60,732 records in&#xa0;the Human Fertilisation and Embryology Authority (HFEA) data. We selected matching records and features through data filtering and feature selection methods. Two groups of twelve machine learning models were trained and tested. Eight metrics, e.g., F1 score, Matthews correlation coefficient (MCC), the area under the receiver operating characteristic curve (AUC), etc., were computed to evaluate the performance of each model.</p>
</sec>
<sec>
<title>Results</title>
<p>Two groups of twelve models were trained and tested. The artificial neural network (ANN) model performed the best in the machine learning group (F1 score, 70.87%; MCC, 50.37%; and AUC score, 0.7939). The LogitBoost model obtained the best scores in the ensemble learning group (F1 score, 70.57%; MCC, 50.75%; and AUC score, 0.7907). After the comparison between the two models, the LogitBoost model was recognized as an optimal one.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In this study, NC-IVF-related datasets were extracted from the HFEA data, and a machine learning-based prediction model was successfully constructed through this largest NC-IVF dataset currently. This model is universal and stable, which can help clinicians predict the live-birth success rate of NC-IVF in advance before developing IVF treatment strategies and then choose the best benefit treatment strategy according to the patients&#x2019; wishes. As &#x201c;use less stimulation and back to natural condition&#x201d; becomes more and more popular, this model is more meaningful in the decision-making assistance system for IVF.</p>
</sec>
</abstract>
<kwd-group>
<kwd>NC-IVF</kwd>
<kwd>HFEA</kwd>
<kwd>machine learning</kwd>
<kwd>ensemble learning</kwd>
<kwd>live birth</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<equation-count count="8"/>
<ref-count count="54"/>
<page-count count="12"/>
<word-count count="6104"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Infertility is defined as failure to achieve a clinical pregnancy after 12 months of regular and unprotected sexual intercourse (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B4">4</xref>). Assisted reproductive technologies (ARTs), especially <italic>in vitro</italic> fertilization (IVF) and embryo transfer (ET) (IVF-ET), are advanced technologies to help infertile couples get pregnant (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). IVF can be divided into natural-cycle IVF (NC-IVF) and stimulated IVF (SIVF) according to whether ovarian stimulation is used or not in the process of IVF. NC-IVF is an IVF cycle without gonadotropins or any other stimulation of follicular growth, and it leads to only one follicle development in most cases. However, SIVF is an IVF cycle that uses gonadotropin stimulation to generate many follicles to improve chances of conception and pregnancy success (<xref ref-type="bibr" rid="B7">7</xref>). The world&#x2019;s first successful IVF pregnancy occurred after NC-IVF in 1978 (<xref ref-type="bibr" rid="B8">8</xref>). Since then, SIVF has been widely used in IVF treatment (<xref ref-type="bibr" rid="B9">9</xref>). At the same time, NC-IVF is only used as an alternative to SIVF and only for patients with poor ovarian responder, advanced age, religious reasons, etc. (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). However, NC-IVF has its unique and irreplaceable advantages: &#x456;) NC-IVF treatment can&#xa0;be performed every month without daily injections, luteal phase support, and adjuncts to improve endometrial function. ii) The endometrium in NC-IVF will not be negatively affected by supraphysiological estradiol concentration (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). iii)&#xa0;Cryopreservation of zygotes or embryos and discarding of surplus embryos is not required in NC-IVF treatment. iv) NC-IVF treatment has no ovarian hyperstimulation syndromes (OHSS) and rare multiple pregnancies (<xref ref-type="bibr" rid="B14">14</xref>). v) The implantation rate per oocyte collected during NC-IVF is higher than that in SIVF, and the embryo quality is also better in NC-IVF (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). vi) NC-IVF treatment has a lower cost per cycle and better perinatal outcomes (<xref ref-type="bibr" rid="B18">18</xref>; <xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B21">21</xref>). vii) The average psychological treatment distress is lower in NC-IVF treatment (<xref ref-type="bibr" rid="B22">22</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>). Briefly, NC-IVF is a low-risk, low-cost, and patient-friendly treatment procedure (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>However, unfortunately, for the purpose and consideration of obtaining as many follicles as possible, doctors generally give priority to recommending SIVF treatment in the current clinical treatment. But even experienced doctors can hardly guarantee which treatment will benefit patients more. If there is a prediction method that can predict the live-birth occurrence using NC-IVF treatment after entering the basic information of patients, can it assist clinicians in developing treatment strategies?</p>
<p>Up till now, reliable and accurate prediction of IVF outcomes has always been an outstanding issue. Meanwhile, applying computational prediction models should be an optimized solution. Computational prediction models estimate the future treatment outcome and offer recommendations by analyzing a variety of related features. With the rapid improvement of computer technology, artificial intelligence (AI) has been explosively developed. Machine learning is an application of AI. It extracts the features of data, trains its capability to analyze features, and develops prediction models based on accumulated experience (intermediate results). Machine learning-based prediction models are increasingly used in clinical decision-making, mostly in complex multi-variable systems (<xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>This study aims to construct a prediction model for live-birth occurrence of NC-IVF, using a comprehensive, varied dataset of 57,558 anonymized register cycle records undergoing NC-IVF cycles from 2005 to 2016 filtered from 760,732 records in the Human Fertilisation and Embryology Authority (HFEA) dataset. Two groups of a total of twelve machine learning models were trained and tested using the dataset. The model construction mainly includes four steps. Step 1: acquire and prepare a dataset, which is the combination of selected and filtered patient records. Step 2: pre-process dataset using specific algorithms to standardize the format, normalize the data, and select features. Step 3: train prediction models with machine learning algorithms in two groups. Step 4: evaluate the performance of each model and find the best one. The overall model building framework is shown in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The overall model building framework.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-838087-g001.tif"/>
</fig>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Data Acquisition</title>
<p>The dataset was obtained from the HFEA, which collected data and statistics about the fertility treatment cycles performed each year in the United Kingdom. HFEA holds the longest-running register of fertility treatments data in the world to improve patient care and help researchers to conduct world-class research while ensuring very strong protection of patient, donor, and offspring confidentiality. The raw dataset in this study contained 760,732 cycle records with 95 fields on treatment cycles started between 2005 and 2016. This study mainly focused on the prediction of live-birth occurrence, so the &#x201c;Live birth occurrence&#x201d; field was regarded as the prediction label, while the other 94 fields were regarded as features. Each record represented patients&#x2019; situations in one cycle. All data were anonymized and freely available on their website (<uri xlink:href="https://www.hfea.gov.uk/">https://www.hfea.gov.uk/</uri>), so no ethics approval was required for this study.</p>
<p>First of all, couples undergoing IVF [including intracytoplasmic sperm injection (ICSI)] were considered. &#x201c;Egg donation,&#x201d; &#x201c;Sperm donation,&#x201d; &#x201c;Embryo donation,&#x201d; and &#x201c;Surrogate&#x201d; were excluded. Secondly, in IVF, exogenous gonadotropins are used to stimulate the development of more than one egg at a time, which is called &#x201c;Stimulation used&#x201d; in the raw dataset (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). So patients who had no &#x201c;Stimulation used&#x201d; (i.e., undergoing NC-IVF) were considered in this study. Then, fresh cycles and the following frozen&#x2013;thawed cycles from NC-IVF were all included. Furthermore, cycles with completed ET were included. Finally, after some records containing outliers such as &#x201c;999&#x201d; were eliminated, 57,558 cycle records were retained for further analysis, i.e., 57,558 NC-IVF cycles.</p>
<p>The raw dataset contains 94 features. Obviously, not all features contributed significantly to predicting live-birth occurrence. As our prediction model was designed as a pretreatment model to predict the live-birth occurrence of the couple before the IVF treatment started, features related to &#x201c;Egg retrieval,&#x201d; &#x201c;Egg stored,&#x201d; &#x201c;Fertilization,&#x201d; &#x201c;Embryo transfer,&#x201d; and &#x201c;Embryo stored&#x201d; were excluded. On the contrary, features related to &#x201c;Patient age,&#x201d; &#x201c;Previous pregnancy status of the couple,&#x201d; &#x201c;Previous pregnancy related treatments,&#x201d; &#x201c;Type of infertility,&#x201d; &#x201c;Cause of infertility,&#x201d; &#x201c;Treatment type,&#x201d; &#x201c;Fresh cycle,&#x201d; and &#x201c;Frozen cycle&#x201d; were included. After these steps, 34 features were selected. A detailed description of selected features is summarized in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Description of 35 fields in the dataset.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Field name</th>
<th valign="top" align="center">Field type</th>
<th valign="top" align="center">Description </th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Patient Age at Treatment</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">Patient age at treatment, banded as follows: 18&#x2013;34, 35&#x2013;37, 38&#x2013;39, 40&#x2013;42, 43&#x2013;44, 45&#x2013;50.</td>
</tr>
<tr>
<td valign="top" align="left">Total Number of Previous Treatments, Both IVF and DI at Clinic</td>
<td valign="top" align="left">Numeric</td>
<td valign="top" align="left">The number of treatment cycles of IVF and DI the patient has previously had at the clinic associated with this treatment.</td>
</tr>
<tr>
<td valign="top" align="left">Total Number of Previous IVF Cycles</td>
<td valign="top" align="left">Numeric</td>
<td valign="top" align="left">The number of treatment cycles of IVF the patient has previously had.</td>
</tr>
<tr>
<td valign="top" align="left">Total Number of Previous DI Cycles</td>
<td valign="top" align="left">Numeric</td>
<td valign="top" align="left">The number of treatment cycles of DI the patient has previously had.</td>
</tr>
<tr>
<td valign="top" align="left">Total Number of IVF Pregnancies</td>
<td valign="top" align="left">Numeric</td>
<td valign="top" align="left">Times the patient has been pregnant through IVF.</td>
</tr>
<tr>
<td valign="top" align="left">Total Number of DI Pregnancies</td>
<td valign="top" align="left">Numeric</td>
<td valign="top" align="left">Times the patient has been pregnant through DI.</td>
</tr>
<tr>
<td valign="top" align="left">Total Number of Live Births&#x2014;Conceived through IVF</td>
<td valign="top" align="left">Numeric</td>
<td valign="top" align="left">The number of live births the patient has had through IVF.</td>
</tr>
<tr>
<td valign="top" align="left">Total Number of Live Births&#x2014;Conceived through DI</td>
<td valign="top" align="left">Numeric</td>
<td valign="top" align="left">The number of live births the patient has had through DI.</td>
</tr>
<tr>
<td valign="top" align="left">Type of Infertility&#x2014;Female Primary</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the patient has never been pregnant, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Type of Infertility&#x2014;Female Secondary</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the patient has ever been pregnant, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Type of Infertility&#x2014;Male Primary</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the partner has never impregnated any woman, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Type of Infertility&#x2014;Male Secondary</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the partner has ever impregnated some woman, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Type of Infertility&#x2014;Couple Primary</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the patient has never been pregnant while the partner has never impregnated any woman,<break/>0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Type of Infertility&#x2014;Couple Secondary</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the patient has ever been pregnant while the partner has ever impregnated some woman,<break/>0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Tubal Disease</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to tubal disease, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Ovulatory Disorder</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to ovulatory disorder, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Male Factor</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to the partner, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Patient Unexplained</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is unknown, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Endometriosis</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to endometriosis, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Cervical Factors</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to cervical factors, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Partner Sperm Concentration</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to partner sperm concentration, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Partner Sperm Morphology</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to partner sperm morphology, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Causes of Infertility&#x2014;Partner Sperm Motility</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to partner sperm motility, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Cause of Infertility&#x2014;Partner Sperm Immunological Factors</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if the primary cause of infertility is due to partner sperm immunological factors, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Main Reason for Producing Embryos Storing Eggs</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">The main reason for storing eggs in this cycle and producing embryos in subsequent cycles, includes treatment now, for storing eggs.</td>
</tr>
<tr>
<td valign="top" align="left">Specific Treatment Type</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">The specific treatment type used in this cycle includes IVF and ICSI.</td>
</tr>
<tr>
<td valign="top" align="left">PGD</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if this cycle involved the use of preimplantation genetic diagnosis, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">PGD Treatment</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if this cycle would be contained in the &#x201c;PGD&#x201d; CaFC category on the HFEA website,<break/>0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">PGS</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if this cycle involved the use of preimplantation genetic screening, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">PGS Treatment</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if this cycle would be contained in the &#x201c;PGS&#x201d; CaFC category on the HFEA website,<break/>0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Elective Single Embryo Transfer</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if this cycle involved the deliberate use of only one embryo, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Fresh Cycle</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if this cycle used fresh embryos, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Frozen Cycle</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if this cycle used frozen embryos, 0 otherwise.</td>
</tr>
<tr>
<td valign="top" align="left">Embryos Transferred</td>
<td valign="top" align="left">Numeric</td>
<td valign="top" align="left">The number of embryos transferred into the patient in this cycle.</td>
</tr>
<tr>
<td valign="top" align="left">Live-Birth Occurrence</td>
<td valign="top" align="left">Categorical</td>
<td valign="top" align="left">1 if there were one or more live births as a result of this cycle, 0 otherwise.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>IVF, in vitro fertilization; DI, donor insemination; ICSI, intracytoplasmic sperm injection; HFEA, Human Fertilisation and Embryology Authority.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2_2">
<title>Data Preprocessing</title>
<p>The data format was standardized into two types: numeric and categorical, e.g., &#x201c;Patient age at treatment,&#x201d; &#x201c;Type of infertility,&#x201d; &#x201c;Cause of infertility,&#x201d; &#x201c;Specific treatment type,&#x201d; and &#x201c;Live birth occurrence&#x201d; were categorical (i.e., two categories: 0 and 1; multiple categories: 0, 1, 2, 3&#x2026;), and &#x201c;Total number of previous IVF cycles,&#x201d; &#x201c;Total number of live births,&#x201d; and &#x201c;Total number of IVF pregnancies&#x201d; were numeric.</p>    <p>The normalization method <italic>via</italic> Z-score was then applied as a pre-processing step to all features (<xref ref-type="bibr" rid="B31">31</xref>). Feature vectors were normalized <italic>via</italic> Z-score normalization, as follows:</p>
<disp-formula>
<mml:math display="block" id="M1">
<mml:mrow>
<mml:msub>
<mml:mi>X</mml:mi>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>X</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>&#x3bc;</mml:mi>
</mml:mrow>
<mml:mi>&#x3c3;</mml:mi>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<p>where <italic>x</italic> is the feature vector, <italic>x<sub>norm</sub>
</italic> is the normalized vector, <italic>&#x3bc;</italic> is the mean value of the feature vector, and <italic>&#x3c3;</italic> is the standard deviation of that. Hence, all feature vectors have a mean of 0 and a standard deviation of 1. After the Z-score normalization step, the classification performance of models would not be affected by the value range of data.</p>
<p>In addition, Pearson&#x2019;s correlation coefficients between 34 features were also calculated. Pairs with a correlation coefficient higher than a threshold (close to 1) were reduced to only one as the input of the model. The correlation matrix of 31 features (after reduction) is shown in <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Correlation matrix of 31 features. The redder grids indicate higher positive correlation values of feature pairs, the bluer ones indicate higher negative correlation values, and the white ones indicate no correlation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-838087-g002.tif"/>
</fig>
</sec>
<sec id="s2_3">
<title>Model Training</title>
<p>After preprocessing, the dataset contained 57,558 samples, including a 57,558 &#xd7; 31 feature matrix and a 57,558 &#xd7; 31 label vector. Among the 57,558 samples, the number of positive samples (i.e., live birth was true) was 12,340, the number of negative samples was 45,218, and the negative samples were nearly four times the positive ones. Obviously, there was a certain degree of imbalance in the dataset. The normal processing methods for dataset imbalance include the following: &#x456;) keeping all positive samples, but down-sampling negative samples, and ii) keeping all negative samples and over-sampling positive samples. The former method will bring a lot of information loss, while the latter one will cause a sharp increase of training dataset and the over-fitting problem (<xref ref-type="bibr" rid="B32">32</xref>). Since the imbalance ratio was not large, and the complexity of model training should not be increased, in this study, the dataset was divided into 4 sub-datasets at a ratio of 1:1, and each sub-dataset contained all positive samples and 1/4 negative samples (the negative samples in the fourth sub-dataset partially overlapped with others, and those in other three sub-datasets were independent with each other). Decision tree (DT) and linear discriminant (LD) algorithms were used to pre-train the four sub-datasets, and then four groups of evaluation metrics including precision, recall, and F1 score were obtained. The sub-dataset with the best score was selected as the dataset for further model training. After this step, the dataset to be used had 24,680 samples, containing exactly the same number of positive and negative samples.</p>
<p>In this study, twelve models were selected, trained, tested, and analyzed. They were divided into two groups: &#x456;) machine learning models, i.e., independent classifiers, included DT, LD, logistic regression (LR), naive Bayes (NB), linear support vector machine (Linear SVM), and artificial neural network (ANN); ii)&#xa0;ensemble learning models, i.e., combined classifiers, including bagged tree (BT), AdaBoost, GentleBoost, LogitBoost, RUSBoost, and random subspace method (RSM).</p>
<p>DT algorithm builds classification or regression models in the form of a tree structure. It breaks down a dataset into smaller and smaller subsets, while at the same time an associated DT is incrementally developed. The final result is a tree with decision nodes and leaf nodes. The topmost decision node in a tree that corresponds to the best predictor is called the root node (<xref ref-type="bibr" rid="B33">33</xref>). LD algorithm, also known as Fisher&#x2019;s LD (FLD), is a classic algorithm for pattern recognition. The basic implementation method is to project high-dimensional samples into the best discriminant vector space to achieve the effect of extracting classification information and compressing the dimension of the feature space (<xref ref-type="bibr" rid="B34">34</xref>). LR algorithm produces a logistic curve, which is limited to values between 0 and 1. The curve is constructed using the natural logarithm of the &#x201c;odds&#x201d; of the target variable, rather than the probability (<xref ref-type="bibr" rid="B35">35</xref>). NB algorithm is based on Bayes&#x2019; theorem with the independence assumptions between predictors. An NB model is easy to build, with no complicated iterative parameter estimation, which makes it particularly useful for very large datasets (<xref ref-type="bibr" rid="B36">36</xref>). SVM algorithm is a kind of generalized linear classifier that helps to identify the maximum-margin hyperplane for the positive and negative classes as a decision boundary. In addition, the SVM algorithm can perform non-linear classification through the kernel method: using a kernel function to map the original training samples to a high-dimensional space. The ANN attempts to recreate the computational mirror of the biological neural network. There are different types of neural networks but are generally classified into feed-forward and feed-back networks. A feed-forward network is a non-recurrent network that contains inputs, outputs, and hidden layers; the signals can only travel in one direction. Input data are passed onto a layer of processing elements where it performs calculations. Each processing element makes its computation based upon a weighted sum of its inputs. The new calculated values then become the new input values that feed the next layer. This process continues until it has gone through all the layers and determines the output (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). In this study a two-layer feed-forward network, with sigmoid hidden and softmax output neurons, was used to classify pattern vectors (live-birth label vector), given 20 neurons in its hidden layer. This network was trained with scaled conjugate gradient backpropagation.</p>
<p>Ensemble learning is a kind of technology that combines a variety of compatible machine learning algorithms/models to perform a single task in order to obtain better prediction performance. Ensemble learning is generally classified into three types: bagging, boosting, and stacking. In this study, two bagging methods (i.e., BT and RSM) and four boosting methods (i.e., AdaBoost, GentleBoost, LogitBoost, and RUSBoost) were built and tested. The bagging method is based on multiple sub-datasets divided through the bootstrap algorithm. Then, multiple models are trained, and the best one is selected using the voting method. In this study, a DT was used as the classifier for the method, so this model was called tree-based bagging or BT (<xref ref-type="bibr" rid="B39">39</xref>). RSM, also known as feature bagging, trains each classifier by using some random features instead of all features to reduce the correlation between each classifier (<xref ref-type="bibr" rid="B40">40</xref>). In this study, LD was used as the classifier for the RSM model. The boosting algorithm combines a series of weak classifiers into a strong classifier to improve performance. The Adaboost algorithm uses class probability estimates to construct real-valued contributions of the weak classifiers, LogitBoost is an adaptive Newton algorithm by stagewise optimization of the Bernoulli likelihood, GentleBoost is an adaptive Newton algorithm <italic>via</italic> stagewise optimization of the exponential loss, RUSBoost is an algorithm combining random undersampling, and RUSBoost is especially for unbalanced datasets (<xref ref-type="bibr" rid="B41">41</xref>&#x2013;<xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>The complete training and validation analysis was implemented <italic>via</italic> MATLAB software (R2020a, Natick, MA, USA). The auxiliary debugging tools were also developed for recording the performance during model training in this environment.</p>
</sec>
<sec id="s2_4">
<title>Assessment Method</title>
<p>A standard validation method was essential to evaluate the performance of each model. In this study, a 10-fold cross-validation method was used to assess the robustness of each model. The dataset was randomly divided into 10 equal-sized subsets, and the cross-validation process was repeated 10 times. Each time, one of the 10 subsets was used as the validation set for testing the model, and the remaining nine subsets were put together to form a training data set. Finally, 10 results of experiments were averaged to produce a single estimation for each model.</p>    <p>The performance of the models was evaluated in terms of common standard machine learning evaluation metrics (<xref ref-type="bibr" rid="B44">44</xref>). These metrics were computed based on the values of true negatives (TN), true positives (TP), false positives (FP), and false negatives (FN) as detailed below.</p>
<disp-formula>
<mml:math display="block" id="M3">
<mml:mrow>
<mml:mi>A</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula>
<mml:math display="block" id="M5">
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>l</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula>
<mml:math display="block" id="M7">
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>f</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>P</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula>
<mml:math display="block" id="M9">
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>V</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>P</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula>
<mml:math display="block" id="M11">
<mml:mrow>
<mml:mi>N</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>V</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula>
<mml:math display="block" id="M13">
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>C</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>&#x2217;</mml:mo>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>&#x2217;</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:msqrt>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>P</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2217;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2217;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>N</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2217;</mml:mo>
<mml:mo>(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mi>N</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula>
<mml:math display="block" id="M15">
<mml:mrow>
<mml:mi>F</mml:mi>
<mml:mn>1</mml:mn>
<mml:mi> </mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi> </mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>&#x2217;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#x2217;</mml:mo>
<mml:mi>R</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>l</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>R</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<p>In addition, confusion matrix plots can help to understand how the currently selected model performed in each class and identify the areas where the model performed poorly (<xref ref-type="bibr" rid="B45">45</xref>). The area under the receiver operating characteristic curve (AUC-ROC) (<xref ref-type="bibr" rid="B46">46</xref>), which also represents the overall performance of model and prediction, has the value ranging from 0 to 1, where 1 represents the best performance and 0 is the worst performance, and AUC = 0.5 means random classification.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Study Population</title>
<p>A total number of 57,558 NC-IVF cycles (samples) were selected in the HFEA dataset from 2005 to 2016.&#xa0;A total of 12,340 cycles resulted in positive live births, while 45,218 cycles resulted in negative live births. Among the 12,340 positive-live-birth cycles, 5,570 received IVF, accounting for 45.14%, and 6,770 received ICSI, accounting for 54.86%. By comparison, among the 45,218 negative-live-birth cycles, 21,539 received IVF, accounting for 47.63%, and 23,679 received ICSI, accounting for 52.37%. The age distribution of all patients undergoing NC-IVF is as follows: 18- to 34-year-old patients accounted for the largest proportion, reaching 42.79%; it is followed by 35- to 37-year-old patients, accounting for 24.84%; and the least was 45- to 50-year-old patients, accounting for 1.24%. In the &#x201c;Type of infertility&#x201d; category, &#x201c;Couple primary&#x201d; accounted for the largest proportion, reaching 34.11%, while &#x201c;Couple secondary&#x201d; had the least proportion, reaching 11.08%. In the category of &#x201c;Cause of infertility,&#x201d; the top five were &#x201c;Male factor&#x201d; (38.09%), &#x201c;Patient unexplained&#x201d; (26.28%), &#x201c;Tubal disease&#x201d; (18.85%), &#x201c;Ovulatory disorder&#x201d; (14.47%), and &#x201c;Endometriosis&#x201d; (5.80%). More detailed statistics are listed in <xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Baseline characteristics of NC-IVF cycles.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="3" align="left">Characteristic</th>
<th valign="top" colspan="4" align="center">NC-IVF cycles 2005&#x2013;2016 (n = 57,558)</th>
</tr>
<tr>
<th valign="top" colspan="2" align="center">Positive live birth (n = 12,340)</th>
<th valign="top" colspan="2" align="center">Negative live birth (n = 45,218)</th>
</tr>
<tr>
<th valign="top" align="center">n</th>
<th valign="top" align="center">%</th>
<th valign="top" align="center">n</th>
<th valign="top" align="center">%</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" colspan="5" align="left"><italic>Patient age at treatment (year)</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;18&#x2013;34</td>
<td valign="top" align="center">6,222</td>
<td valign="top" align="center">50.42</td>
<td valign="top" align="center">18,409</td>
<td valign="top" align="center">4.09</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;35&#x2013;37</td>
<td valign="top" align="center">3,211</td>
<td valign="top" align="center">26.02</td>
<td valign="top" align="center">11,089</td>
<td valign="top" align="center">24.52</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;38&#x2013;39</td>
<td valign="top" align="center">1,642</td>
<td valign="top" align="center">13.31</td>
<td valign="top" align="center">6,824</td>
<td valign="top" align="center">15.09</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;40&#x2013;42</td>
<td valign="top" align="center">1,060</td>
<td valign="top" align="center">8.59</td>
<td valign="top" align="center">6,478</td>
<td valign="top" align="center">14.33</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;43&#x2013;44</td>
<td valign="top" align="center">163</td>
<td valign="top" align="center">1.32</td>
<td valign="top" align="center">1,747</td>
<td valign="top" align="center">3.86</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;45&#x2013;50</td>
<td valign="top" align="center">42</td>
<td valign="top" align="center">0.34</td>
<td valign="top" align="center">671</td>
<td valign="top" align="center">1.48</td>
</tr>
<tr>
<td valign="top" colspan="5" align="left"><italic>Type of infertility</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Female primary</td>
<td valign="top" align="center">3,186</td>
<td valign="top" align="center">25.82</td>
<td valign="top" align="center">13,642</td>
<td valign="top" align="center">30.17</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Female secondary</td>
<td valign="top" align="center">1,667</td>
<td valign="top" align="center">13.51</td>
<td valign="top" align="center">7,597</td>
<td valign="top" align="center">16.80</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Male primary</td>
<td valign="top" align="center">3,171</td>
<td valign="top" align="center">25.70</td>
<td valign="top" align="center">13,515</td>
<td valign="top" align="center">29.89</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Male secondary</td>
<td valign="top" align="center">1,655</td>
<td valign="top" align="center">13.41</td>
<td valign="top" align="center">7,608</td>
<td valign="top" align="center">16.83</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Couple primary</td>
<td valign="top" align="center">3,678</td>
<td valign="top" align="center">29.81</td>
<td valign="top" align="center">15,867</td>
<td valign="top" align="center">35.09</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Couple secondary</td>
<td valign="top" align="center">1,151</td>
<td valign="top" align="center">9.33</td>
<td valign="top" align="center">5,227</td>
<td valign="top" align="center">11.56</td>
</tr>
<tr>
<td valign="top" colspan="5" align="left"><italic>Cause of infertility</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Tubal disease</td>
<td valign="top" align="center">2,029</td>
<td valign="top" align="center">16.44</td>
<td valign="top" align="center">8,818</td>
<td valign="top" align="center">19.50</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Ovulatory disorder</td>
<td valign="top" align="center">1,844</td>
<td valign="top" align="center">14.94</td>
<td valign="top" align="center">6,484</td>
<td valign="top" align="center">14.34</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Male factor</td>
<td valign="top" align="center">4,916</td>
<td valign="top" align="center">39.84</td>
<td valign="top" align="center">17,007</td>
<td valign="top" align="center">37.61</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Patient unexplained</td>
<td valign="top" align="center">3,191</td>
<td valign="top" align="center">25.86</td>
<td valign="top" align="center">11,933</td>
<td valign="top" align="center">26.39</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Endometriosis</td>
<td valign="top" align="center">725</td>
<td valign="top" align="center">5.88</td>
<td valign="top" align="center">2,614</td>
<td valign="top" align="center">5.78</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Cervical factors</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">0.05</td>
<td valign="top" align="center">27</td>
<td valign="top" align="center">0.06</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Partner sperm concentration</td>
<td valign="top" align="center">47</td>
<td valign="top" align="center">0.38</td>
<td valign="top" align="center">235</td>
<td valign="top" align="center">0.52</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Partner sperm morphology</td>
<td valign="top" align="center">40</td>
<td valign="top" align="center">0.32</td>
<td valign="top" align="center">144</td>
<td valign="top" align="center">0.32</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Partner sperm motility</td>
<td valign="top" align="center">23</td>
<td valign="top" align="center">0.19</td>
<td valign="top" align="center">116</td>
<td valign="top" align="center">0.37</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Partner sperm<break/>&#x2003;Immunological factors</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.01</td>
</tr>
<tr>
<td valign="top" colspan="5" align="left"><italic>Specific treatment type</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;IVF</td>
<td valign="top" align="center">5,570</td>
<td valign="top" align="center">45.14</td>
<td valign="top" align="center">21,539</td>
<td valign="top" align="center">47.63</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;ICSI</td>
<td valign="top" align="center">6,770</td>
<td valign="top" align="center">54.86</td>
<td valign="top" align="center">23,679</td>
<td valign="top" align="center">52.37</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Model Assessment and Comparison</title>
<p>The evaluation metrics of all models were compared in terms of accuracy, recall, specificity, precision, negative predictive value (NPV), Matthews correlation coefficient (MCC), and F1 score as listed in <xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>. Among the six machine learning models, ANN, LR, and LD models achieved the best F1 scores (70.87%, 70.82%, and 70.68%, respectively). As shown in <xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>, ANN, LR, and LD models also obtained the best AUC scores (0.7939, 0.7911, and 0.7910, respectively). Although the scores of the three models were very close, obviously, the ANN model performed the best in terms of metrics.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Evaluation metrics of all models.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Model</th>
<th valign="top" align="center">Accuracy</th>
<th valign="top" align="center">Recall</th>
<th valign="top" align="center">Specificity</th>
<th valign="top" align="center">Precision</th>
<th valign="top" align="center">NPV</th>
<th valign="top" align="center">MCC</th>
<th valign="top" align="center">F1</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" colspan="8" align="left"><bold>Machine learning models</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">DT</td>
<td valign="top" align="center">74.19</td>
<td valign="top" align="center">61.90</td>
<td valign="top" align="center">86.47</td>
<td valign="top" align="center">82.06</td>
<td valign="top" align="center">69.42</td>
<td valign="top" align="center">49.90</td>
<td valign="top" align="center">70.57</td>
</tr>
<tr>
<td valign="top" align="left">LD</td>
<td valign="top" align="center">74.44</td>
<td valign="top" align="center">61.62</td>
<td valign="top" align="center">87.26</td>
<td valign="top" align="center">82.87</td>
<td valign="top" align="center">69.45</td>
<td valign="top" align="center">50.57</td>
<td valign="top" align="center">70.68</td>
</tr>
<tr>
<td valign="top" align="left">LR</td>
<td valign="top" align="center">74.34</td>
<td valign="top" align="center">62.27</td>
<td valign="top" align="center">86.42</td>
<td valign="top" align="center">82.10</td>
<td valign="top" align="center">69.59</td>
<td valign="top" align="center">50.17</td>
<td valign="top" align="center">70.82</td>
</tr>
<tr>
<td valign="top" align="left">NB</td>
<td valign="top" align="center">57.14</td>
<td valign="top" align="center">15.57</td>
<td valign="top" align="center">98.72</td>
<td valign="top" align="center">92.40</td>
<td valign="top" align="center">53.90</td>
<td valign="top" align="center">25.72</td>
<td valign="top" align="center">26.65</td>
</tr>
<tr>
<td valign="top" align="left">Linear SVM</td>
<td valign="top" align="center">74.38</td>
<td valign="top" align="center">60.72</td>
<td valign="top" align="center">88.04</td>
<td valign="top" align="center">83.54</td>
<td valign="top" align="center">69.15</td>
<td valign="top" align="center">50.69</td>
<td valign="top" align="center">70.33</td>
</tr>
<tr>
<td valign="top" align="left">ANN</td>
<td valign="top" align="center">74.42</td>
<td valign="top" align="center">62.24</td>
<td valign="top" align="center">86.61</td>
<td valign="top" align="center">82.30</td>
<td valign="top" align="center">69.64</td>
<td valign="top" align="center">50.37</td>
<td valign="top" align="center">70.87</td>
</tr>
<tr>
<td valign="top" colspan="8" align="left"><bold>Ensemble learning models</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">BT</td>
<td valign="top" align="center">67.78</td>
<td valign="top" align="center">72.88</td>
<td valign="top" align="center">62.69</td>
<td valign="top" align="center">66.14</td>
<td valign="top" align="center">69.80</td>
<td valign="top" align="center">35.75</td>
<td valign="top" align="center">69.34</td>
</tr>
<tr>
<td valign="top" align="left">AdaBoost</td>
<td valign="top" align="center">74.37</td>
<td valign="top" align="center">61.33</td>
<td valign="top" align="center">87.41</td>
<td valign="top" align="center">82.97</td>
<td valign="top" align="center">69.33</td>
<td valign="top" align="center">50.49</td>
<td valign="top" align="center">70.53</td>
</tr>
<tr>
<td valign="top" align="left">GentleBoost</td>
<td valign="top" align="center">73.85</td>
<td valign="top" align="center">62.87</td>
<td valign="top" align="center">84.82</td>
<td valign="top" align="center">80.55</td>
<td valign="top" align="center">69.55</td>
<td valign="top" align="center">48.88</td>
<td valign="top" align="center">70.62</td>
</tr>
<tr>
<td valign="top" align="left">LogitBoost</td>
<td valign="top" align="center">74.47</td>
<td valign="top" align="center">61.22</td>
<td valign="top" align="center">87.72</td>
<td valign="top" align="center">83.29</td>
<td valign="top" align="center">69.34</td>
<td valign="top" align="center">50.75</td>
<td valign="top" align="center">70.57</td>
</tr>
<tr>
<td valign="top" align="left">RUSBoost</td>
<td valign="top" align="center">74.33</td>
<td valign="top" align="center">61.22</td>
<td valign="top" align="center">87.44</td>
<td valign="top" align="center">82.98</td>
<td valign="top" align="center">69.28</td>
<td valign="top" align="center">50.43</td>
<td valign="top" align="center">70.46</td>
</tr>
<tr>
<td valign="top" align="left">RSM</td>
<td valign="top" align="center">74.41</td>
<td valign="top" align="center">61.28</td>
<td valign="top" align="center">87.54</td>
<td valign="top" align="center">83.11</td>
<td valign="top" align="center">69.33</td>
<td valign="top" align="center">50.60</td>
<td valign="top" align="center">70.54</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The values in the table represent percentages.</p>
</fn>
<fn>
<p>NPV, negative predictive value; MCC, Matthews correlation coefficient; DT, decision tree; LD, linear discriminant; LR, logistic regression; NB, naive Bayes; SVM, support vector machine; ANN, artificial neural network; BT, bagged tree; RSM, random subspace method.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The ROC curves and AUC scores of six machine learning models. <bold>(A)</bold> The ROC curve and AUC score of the DT model: the deep purple curve refers to the ROC curve, the area under the curve is covered by light purple color, the orange dot represents the threshold that corresponds to the optimal operating point, and the AUC score is clearly marked. <bold>(B&#x2013;F)</bold> The ROC curve and AUC score of LD, LR, NB, Linear SVM, and ANN, respectively. ROC, receiver operating characteristic; AUC, area under the receiver operating characteristic curve; DT, decision tree; LD, linear discriminant; LR, logistic regression; NB, naive Bayes; ANN, artificial neural network.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-838087-g003.tif"/>
</fig>
<p>Among the six ensemble learning models, the performance differences were slight except for the BT model. GentleBoost, LogitBoost, and RSM models achieved the best F1 scores (70.62%, 70.57%, and 70.54%, respectively) as listed in <xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref> and the best AUC scores (0.7839, 0.7907, and 0.7892, respectively) as shown in <xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>. Moreover, LogitBoost obtained another best score, i.e., MCC (50.75%), which is defined as a comprehensive indicator like the F1 score. In summary, the LogitBoost model was considered the best performer after comparison with other ensemble learning models.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The ROC curves and AUC scores of six ensemble learning models. <bold>(A)</bold> The ROC curve and AUC score of BT model: the deep purple curve refers to the ROC curve, the area under the curve is covered by light purple color, the orange dot represents the threshold that corresponds to the optimal operating point, and the AUC score is clearly marked. <bold>(B&#x2013;F)</bold> The ROC curve and AUC score of AdaBoost, GentleBoost, LogitBoost, RUSBoost, and RSM, respectively. ROC, receiver operating characteristic; AUC, area under the receiver operating characteristic curve; BT, bagged tree; RSM, random subspace method.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-838087-g004.tif"/>
</fig>
<p>A comprehensive comparison of all models is shown in <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5</bold></xref>. The ROC curve of the ANN model covered the largest area among the six machine learning models in <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5A</bold></xref>, while the ROC curve of the LogitBoost model covered the largest area among the six ensemble learning models in <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5B</bold></xref>. The comparison of ROC curves between the ANN model and the LogitBoost model in <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5C</bold></xref> implied that the performance difference might be very small, and the stacking effect of all metrics could also illustrate this point as shown in <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5D</bold></xref>.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Comprehensive comparison of all models. <bold>(A)</bold> Comprehensive ROC curves of six machine learning models: the larger the area under the curve, the better the performance. <bold>(B)</bold> Comprehensive ROC curves of six ensemble learning models. <bold>(C)</bold> Comprehensive comparison of two ROC curves: ANN model, i.e., the best machine learning model, and LogitBoost model, i.e., the best ensemble learning model. <bold>(D)</bold> In this histogram, the metrics of twelve models, including accuracy, recall, specificity, precision, NPV, MCC, F1, and AUC, are stacked into columns; hence, the higher the column, the better the performance. ROC, receiver operating characteristic; ANN, artificial neural network; NPV, negative predictive value; MCC, Matthews correlation coefficient.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-838087-g005.tif"/>
</fig>
<p>ANN and LogitBoost are two completely different algorithm models. In this study, we found that the two models achieved almost indistinguishable performance. In other words, the two models had almost the same prediction abilities under this specific dataset. Finally, we also included the training time in the performance evaluation. Under the specific computer platform involved in this study, the training time of ANN was about 89.804 s, while that of LogitBoost was about 11.193 s. Obviously, the training efficiency of LogitBoost is higher than ANN, so the LogitBoost model would be considered the optimal model and software would be designed for actual prediction.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Machine learning has become a new discipline, which integrates the application of psychology, biology, neurophysiology, mathematics, automation science, and computer science to form the theoretical basis of machine learning. Currently, machine learning has rapidly demonstrated its ability to predict human fertility (<xref ref-type="bibr" rid="B47">47</xref>). So far, the main studies using machine learning models to predict better IVF outcomes are as follows: &#x456;) a deep convolutional neural network (CNN) model was trained to assess an embryo&#x2019;s implantation potential (<xref ref-type="bibr" rid="B48">48</xref>). ii) AI technology based on determinant-weighting analysis could offer an individualized embryo selection strategy for any given patient and predict clinical pregnancy rate and twin risk (<xref ref-type="bibr" rid="B49">49</xref>). iii) A machine learning algorithm could use clinical parameters and markers of capacitation to predict successful fertilization in normospermic men undergoing IVF (<xref ref-type="bibr" rid="B50">50</xref>). iv) A random forest (RF) model was built to predict the implantation potential of a transferred embryo (<xref ref-type="bibr" rid="B51">51</xref>). Moreover, the relevant studies using the HFEA dataset for analysis and prediction are as follows: &#x456;) a logistic model was fitted to predict the live-birth rate following IVF based on the number of eggs and the age of the female using HFEA data (<xref ref-type="bibr" rid="B52">52</xref>). ii) Two clinical prediction models were developed to estimate the individualized cumulative chance of a first live birth over a maximum of six complete cycles of IVF using HFEA data (<xref ref-type="bibr" rid="B53">53</xref>). iii) Three clinical models were used to assess live birth and perinatal outcomes with the HFEA database (<xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>Whether using AI prediction models or clinical prediction models and whether based on small samples from single-center or big data from expert organizations like HFEA, current studies focused on the associations between IVF outcome and embryo morphology, embryo quality, embryo freezing, etc. The connection between IVF outcome and a different ovarian stimulation was rarely reported. In fact, a different ovarian stimulation directly determines the number of eggs obtained and the egg quality, which are directly related to the embryo quality, and embryo quality is the key factor affecting IVF outcome. Before an actual IVF treatment, what kind of ovarian stimulation is the first choice that the patients need to face. Due to a lack of expertise in patients, the use of ovarian stimulation is mainly based on the recommendation and judgment of clinicians. But even experienced clinicians can hardly guarantee which kind of ovarian stimulation results in a better outcome. IVF technology has only been developed for decades. The long-term potential impact of &#x201c;stimulation used&#x201d; on offspring is currently unknown. Today, more and more people are calling for &#x201c;back to nature,&#x201d; to simulate the conception process in the natural state as much as possible. It seems to be of great value to predict the outcome of such a natural process.</p>
<p>We creatively incorporated the ovarian stimulation scheme into the basic conditions of big data filtering and research. After selecting the NC-IVF records from the HFEA dataset, which is one of the largest IVF datasets in the world, we built a live-birth prediction model and provided greater precision than previous individual studies. To our knowledge, the dataset in this study is the largest one focusing on NC-IVF by now. The prediction model is universal and stable, which can help clinicians predict the live-birth success rate of NC-IVF in advance before developing IVF treatment strategies and then choose the best benefit treatment strategy according to the patients&#x2019; wishes. If the success rate is high, the patients will be recommended to enter an NC-IVF cycle. Otherwise, a SIVF cycle can be considered to generate many follicles to improve chances for conception and pregnancy (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>The limitations of this study include the live-birth occurrence prediction for cumulative NC-IVF cycles not being studied. As the HFEA data were anonymized cycle-based records rather than patient-based, we were unable to identify patients who had undergone more than one cycle in the dataset. Furthermore, some features, e.g., smoking, body mass index (BMI), the number of good-quality embryos, the total dose of gonadotropins, and the methods of freezing or thawing embryos, have been reported and confirmed to be related to the IVF outcome. As the HFEA data did not include these records, our study was not comprehensive enough. Besides, the HFEA data only represent the anonymized patients from the United Kingdom. If possible, in the future, we will include anonymized data from more institutions, regions, and even more races. This study only focused on NC-IVF cycles. In the next step, the study of SIVF will also be considered to provide a more comprehensive prediction method.</p>
<p>In conclusion, previous studies on live-birth prediction of NC-IVF were very few, the sample size was very limited, and most of the studies were based on women under unfavorable conditions, which might lead to low reliability of results. In this study, NC-IVF-related datasets were extracted from the HFEA data, and a machine learning-based prediction model was successfully constructed through this largest NC-IVF dataset currently. A total of twelve machine learning models were trained, and the best one was selected to predict the live birth. This model is universal and stable, which can help clinicians predict the live-birth success rate of NC-IVF in advance before developing IVF treatment strategies and then choose the best benefit treatment strategy according to the patients&#x2019; wishes. We hope that similar models should be promoted so that the IVF treatment can &#x201c;use less stimulation and back to natural condition,&#x201d; for the purpose of reducing the burdens and risks of patients and reducing the potential risks of offspring due to stimulation as much as possible.</p>
<p>An application software based on the prediction model will be developed. Once the patient&#x2019;s data (features) are entered into the software, a prediction result (positive or negative, and probability) will be displayed. Combined with the experience of clinicians, it can obviously assist in decision-making. Therefore, this is the basic idea of an intelligent decision support system. Moreover, with the continuous expansion of the dataset, for example, more cycle records are obtained from the HFEA, the model will be updated to achieve higher accuracy.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <uri xlink:href="https://www.hfea.gov.uk/about-us/our-data/#ar">https://www.hfea.gov.uk/about-us/our-data/#ar</uri>.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>Ethical review and approval were not required for the study on human participants in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author Contributions</title>
<p>YZ and LS initiated and conceived the study. YZ was responsible for data acquisition and data preprocessing. LS was responsible for model construction. YZ and LS wrote the manuscript. XY and WC advised on the development of the study and revised and commented on the draft. All authors read and approved the final version of the manuscript.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors thank the Human Fertilisation and Embryology Authority for providing the dataset free of charge.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evers</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Female Subfertility</article-title>. <source>Lancet</source> (<year>2002</year>) <volume>360</volume>(<issue>9327</issue>):<page-range>151&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(02)09417-5</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurunath</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pandian</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Defining Infertility&#x2013;A&#xa0;Systematic Review of Prevalence Studies</article-title>. <source>Hum Reprod Update</source> (<year>2011</year>) <volume>17</volume>(<issue>5</issue>):<page-range>575&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humupd/dmr015</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farquhar</surname> <given-names>C</given-names>
</name>
<name>
<surname>Marjoribanks</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Assisted Reproductive Technology: An Overview of Cochrane Reviews</article-title>. <source>Cochrane Database Syst Rev</source> (<year>2018</year>) <volume>8</volume>:<elocation-id>CD010537</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/14651858.CD010537.pub5</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vander Borght</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wyns</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Fertility and Infertility: Definition and Epidemiology</article-title>. <source>Clin Biochem</source> (<year>2018</year>) <volume>62</volume>:<fpage>2</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2018.03.012</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niederberger</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pellicer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cohen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gardner</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Palermo</surname> <given-names>GD</given-names>
</name>
<name>
<surname>O'Neill</surname> <given-names>CL</given-names>
</name>
<etal/>
</person-group>. <article-title>Forty Years of IVF</article-title>. <source>Fertil Steril</source> (<year>2018</year>) <volume>110</volume>(<issue>2</issue>):<fpage>185</fpage>&#x2013;<lpage>324.e185</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fertnstert.2018.06.005</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Human <italic>In Vitro</italic> Fertilisation and Developmental Biology: A Mutually Influential History</article-title>. <source>Development</source> (<year>2019</year>) <volume>146</volume>(<issue>17</issue>):<elocation-id>dev183145</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dev.183145</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macklon</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Stouffer</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Giudice</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Fauser</surname> <given-names>BC</given-names>
</name>
</person-group>. <article-title>The Science Behind 25 Years of Ovarian Stimulation for <italic>In Vitro</italic> Fertilization</article-title>. <source>Endocr Rev</source> (<year>2006</year>) <volume>27</volume>(<issue>2</issue>):<fpage>170</fpage>&#x2013;<lpage>207</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/er.2005-0015</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steptoe</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Edwards</surname> <given-names>RG</given-names>
</name>
</person-group>. <article-title>Birth After the Reimplantation of a Human Embryo</article-title>. <source>Lancet</source> (<year>1978</year>) <volume>2</volume>(<issue>8085</issue>):<fpage>366</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(78)92957-4</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Wolff</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The Role of Natural Cycle IVF in Assisted Reproduction</article-title>. <source>Best Pract Res Clin Endocrinol Metab</source> (<year>2019</year>) <volume>33</volume>(<issue>1</issue>):<fpage>35</fpage>&#x2013;<lpage>45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.beem.2018.10.005</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schimberni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Morgia</surname> <given-names>F</given-names>
</name>
<name>
<surname>Colabianchi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Giallonardo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Piscitelli</surname> <given-names>C</given-names>
</name>
<name>
<surname>Giannini</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Natural-Cycle <italic>In Vitro</italic> Fertilization in Poor Responder Patients: A Survey of 500 Consecutive Cycles</article-title>. <source>Fertil Steril</source> (<year>2009</year>) <volume>92</volume>(<issue>4</issue>):<page-range>1297&#x2013;301</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fertnstert.2008.07.1765</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roesner</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pflaumer</surname> <given-names>U</given-names>
</name>
<name>
<surname>Germeyer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Montag</surname> <given-names>M</given-names>
</name>
<name>
<surname>Strowitzki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Toth</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Natural Cycle IVF: Evaluation of 463 Cycles and Summary of the Current Literature</article-title>. <source>Arch Gynecol Obstet</source> (<year>2014</year>) <volume>289</volume>(<issue>6</issue>):<page-range>1347&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00404-013-3123-2</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonagura</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Pepe</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Enders</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Albrecht</surname> <given-names>ED</given-names>
</name>
</person-group>. <article-title>Suppression of Extravillous Trophoblast Vascular Endothelial Growth Factor Expression and Uterine Spiral Artery Invasion by Estrogen During Early Baboon Pregnancy</article-title>. <source>Endocrinology</source> (<year>2008</year>) <volume>149</volume>(<issue>10</issue>):<page-range>5078&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2008-0116</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mainigi</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Olalere</surname> <given-names>D</given-names>
</name>
<name>
<surname>Burd</surname> <given-names>I</given-names>
</name>
<name>
<surname>Sapienza</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bartolomei</surname> <given-names>M</given-names>
</name>
<name>
<surname>Coutifaris</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Peri-Implantation Hormonal Milieu: Elucidating Mechanisms of Abnormal Placentation and Fetal Growth</article-title>. <source>Biol Reprod</source> (<year>2014</year>) <volume>90</volume>(<issue>2</issue>):<fpage>26</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1095/biolreprod.113.110411</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blumenfeld</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>The Ovarian Hyperstimulation Syndrome</article-title>. <source>Vitam Horm</source> (<year>2018</year>) <volume>107</volume>:<page-range>423&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/bs.vh.2018.01.018</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kollmann</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Bersinger</surname> <given-names>NA</given-names>
</name>
<name>
<surname>McKinnon</surname> <given-names>BD</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mueller</surname> <given-names>MD</given-names>
</name>
<name>
<surname>von Wolff</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Anti-Mullerian Hormone and Progesterone Levels Produced by Granulosa Cells are Higher When Derived From Natural Cycle IVF Than From Conventional Gonadotropin-Stimulated IVF</article-title>. <source>Reprod Biol Endocrinol</source> (<year>2015</year>) <volume>13</volume>:<fpage>21</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12958-015-0017-0</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lainas</surname> <given-names>TG</given-names>
</name>
<name>
<surname>Sfontouris</surname> <given-names>IA</given-names>
</name>
<name>
<surname>Venetis</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Lainas</surname> <given-names>GT</given-names>
</name>
<name>
<surname>Zorzovilis</surname> <given-names>IZ</given-names>
</name>
<name>
<surname>Tarlatzis</surname> <given-names>BC</given-names>
</name>
<etal/>
</person-group>. <article-title>Live Birth Rates After Modified Natural Cycle Compared With High-Dose FSH Stimulation Using GnRH Antagonists in Poor Responders</article-title>. <source>Hum Reprod</source> (<year>2015</year>) <volume>30</volume>(<issue>10</issue>):<page-range>2321&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/dev198</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kollmann</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>S</given-names>
</name>
<name>
<surname>Fux</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bersinger</surname> <given-names>NA</given-names>
</name>
<name>
<surname>von Wolff</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Gonadotrophin Stimulation in IVF Alters the Immune Cell Profile in Follicular Fluid and the Cytokine Concentrations in Follicular Fluid and Serum</article-title>. <source>Hum Reprod</source> (<year>2017</year>) <volume>32</volume>(<issue>4</issue>):<page-range>820&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/dex005</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname> <given-names>AN</given-names>
</name>
<name>
<surname>Goossens</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ferraretti</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>S</given-names>
</name>
<name>
<surname>Felberbaum</surname> <given-names>R</given-names>
</name>
<name>
<surname>de Mouzon</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Assisted Reproductive Technology in Europe, 2004: Results Generated From European Registers by ESHRE</article-title>. <source>Hum Reprod</source> (<year>2008</year>) <volume>23</volume>(<issue>4</issue>):<page-range>756&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/den014</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Wolff</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rohner</surname> <given-names>S</given-names>
</name>
<name>
<surname>Santi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Stute</surname> <given-names>P</given-names>
</name>
<name>
<surname>Popovici</surname> <given-names>R</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Modified Natural Cycle <italic>In Vitro</italic> Fertilization an Alternative <italic>In Vitro</italic> Fertilization Treatment With Lower Costs Per Achieved Pregnancy But Longer Treatment Time</article-title>. <source>J Reprod Med</source> (<year>2014</year>) <volume>59</volume>(<issue>11-12</issue>):<page-range>553&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1007/978-81-322-1118-1_3</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamath</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Kirubakaran</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mascarenhas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sunkara</surname> <given-names>SK</given-names>
</name>
</person-group>. <article-title>Perinatal Outcomes After Stimulated Versus Natural Cycle IVF: A Systematic Review and Meta-Analysis</article-title>. <source>Reprod BioMed Online</source> (<year>2018</year>) <volume>36</volume>(<issue>1</issue>):<fpage>94</fpage>&#x2013;<lpage>101</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.rbmo.2017.09.009</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maheshwari</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pandey</surname> <given-names>S</given-names>
</name>
<name>
<surname>Amalraj Raja</surname> <given-names>E</given-names>
</name>
<name>
<surname>Shetty</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hamilton</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Is Frozen Embryo Transfer Better for Mothers and Babies? Can Cumulative Meta-Analysis Provide a Definitive Answer</article-title>? <source>Hum Reprod Update</source> (<year>2018</year>) <volume>24</volume>(<issue>1</issue>):<fpage>35</fpage>&#x2013;<lpage>58</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humupd/dmx031</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eugster</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vingerhoets</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Psychological Aspects of <italic>In Vitro</italic> Fertilization: A Review</article-title>. <source>Soc Sci Med</source> (<year>1999</year>) <volume>48</volume>(<issue>5</issue>):<page-range>575&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0277-9536(98)00386-4</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gameiro</surname> <given-names>S</given-names>
</name>
<name>
<surname>Boivin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Peronace</surname> <given-names>L</given-names>
</name>
<name>
<surname>Verhaak</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Why do Patients Discontinue Fertility Treatment? A Systematic Review of Reasons and Predictors of Discontinuation in Fertility Treatment</article-title>. <source>Hum Reprod Update</source> (<year>2012</year>) <volume>18</volume>(<issue>6</issue>):<page-range>652&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humupd/dms031</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haemmerli Keller</surname> <given-names>K</given-names>
</name>
<name>
<surname>Alder</surname> <given-names>G</given-names>
</name>
<name>
<surname>Loewer</surname> <given-names>L</given-names>
</name>
<name>
<surname>Faeh</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rohner</surname> <given-names>S</given-names>
</name>
<name>
<surname>von Wolff</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Treatment-Related Psychological Stress in Different <italic>In Vitro</italic> Fertilization Therapies With and Without Gonadotropin Stimulation</article-title>. <source>Acta Obstet Gynecol Scand</source> (<year>2018</year>) <volume>97</volume>(<issue>3</issue>):<page-range>269&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/aogs.13281</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelinck</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Hoek</surname> <given-names>A</given-names>
</name>
<name>
<surname>Simons</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Heineman</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Efficacy of Natural Cycle IVF: A Review of the Literature</article-title>. <source>Hum Reprod Update</source> (<year>2002</year>) <volume>8</volume>(<issue>2</issue>):<page-range>129&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humupd/8.2.129</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deo</surname> <given-names>RC</given-names>
</name>
</person-group>. <article-title>Machine Learning in Medicine</article-title>. <source>Circulation</source> (<year>2015</year>) <volume>132</volume>(<issue>20</issue>):<page-range>1920&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.001593</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obermeyer</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Emanuel</surname> <given-names>EJ</given-names>
</name>
</person-group>. <article-title>Predicting the Future - Big Data, Machine Learning, and Clinical Medicine</article-title>. <source>N Engl J Med</source> (<year>2016</year>) <volume>375</volume>(<issue>13</issue>):<page-range>1216&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMp1606181</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jovic</surname> <given-names>S</given-names>
</name>
<name>
<surname>Miljkovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ivanovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Saranovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Arsic</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Prostate Cancer Probability Prediction By Machine Learning Technique</article-title>. <source>Cancer Invest</source> (<year>2017</year>) <volume>35</volume>(<issue>10</issue>):<page-range>647&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/07357907.2017.1406496</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahemmed</surname> <given-names>B</given-names>
</name>
<name>
<surname>Sundarapandian</surname> <given-names>V</given-names>
</name>
<name>
<surname>Gutgutia</surname> <given-names>R</given-names>
</name>
<name>
<surname>Balasubramanyam</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jagtap</surname> <given-names>R</given-names>
</name>
<name>
<surname>Biliangady</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology</article-title>. <source>Int J Reprod Med</source> (<year>2017</year>) <volume>2017</volume>:<elocation-id>9451235</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/9451235</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goyal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kuchana</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ayyagari</surname> <given-names>KPR</given-names>
</name>
</person-group>. <article-title>Machine Learning Predicts Live-Birth Occurrence Before <italic>in-Vitro</italic> Fertilization Treatment</article-title>. <source>Sci Rep</source> (<year>2020</year>) <volume>10</volume>(<issue>1</issue>):<fpage>20925</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-76928-z</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shiffler</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>Maximum Z Scores and Outliers</article-title>. <source>Am Stat</source> (<year>1988</year>) <volume>42</volume>(<issue>1</issue>):<fpage>79</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1080/00031305.1988.10475530</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bekkar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Alitouche</surname> <given-names>TA</given-names>
</name>
</person-group>. <article-title>Imbalanced Data Learning Approaches Review</article-title>. <source>Int J Data Min Knowl Manage Proc</source> (<year>2013</year>) <volume>3</volume>(<issue>4</issue>):<fpage>15</fpage>&#x2013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.5121/ijdkp.2013.3402</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breiman</surname> <given-names>LI</given-names>
</name>
<name>
<surname>Friedman</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Olshen</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Stone</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Classification and Regression Trees</article-title>. <source>Biometrics</source> (<year>1984</year>) <volume>40</volume>(<issue>3</issue>):<fpage>874</fpage>. doi: <pub-id pub-id-type="doi">10.2307/2530946</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daniela</surname> <given-names>M</given-names>
</name>
<name>
<surname>Witten</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tibshirani</surname></name>
</person-group>. <article-title>Penalized Classification Using Fisher's Linear Discriminant</article-title>. <source>J R Stat Soc: Ser B</source> (<year>2011</year>) <volume>73</volume>(<issue>5</issue>):<page-range>753&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1467-9868.2011.00783.x</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dreiseitl</surname> <given-names>S</given-names>
</name>
<name>
<surname>Machado</surname> <given-names>LO</given-names>
</name>
</person-group>. <article-title>Logistic Regression and Artificial Neural Network Classification Models: A Methodology Review</article-title>. <source>J Biomed Inf</source> (<year>2002</year>) <volume>35</volume>(<issue>5&#x2013;6</issue>):<page-range>352&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1532-0464(03)00034-0</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domingos</surname> <given-names>P</given-names>
</name>
<name>
<surname>Pazzani</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>On the Optimality of the Simple Bayesian Classifier Under Zero-One Loss</article-title>. <source>Mach Learn</source> (<year>1997</year>) <volume>29</volume>(<issue>2-3</issue>):<page-range>103&#x2013;30</page-range>. doi: <pub-id pub-id-type="doi">10.1023/A:1007413511361</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katz</surname> <given-names>WT</given-names>
</name>
<name>
<surname>Snell</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Merickel</surname> <given-names>MB</given-names>
</name>
</person-group>. <article-title>Artificial Neural Networks</article-title>. <source>Methods Enzymol</source> (<year>1992</year>) <volume>210</volume>(<issue>210</issue>):<page-range>610&#x2013;36</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0076-6879(92)10031-8</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mohiuddin</surname> <given-names>KM</given-names>
</name>
</person-group>. <article-title>Artificial Neural Networks: A Tutorial</article-title>. <source>Computer</source> (<year>2015</year>) <volume>29</volume>(<issue>3</issue>):<fpage>31</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1109/2.485891</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breiman</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Bagging Predictors</article-title>. <article-title>Artificial Neural Networks</article-title>. <source>Mach Learn</source> (<year>1996</year>) <volume>24</volume>:<page-range>123&#x2013;40</page-range>. doi: <pub-id pub-id-type="doi">10.1007/BF00058655</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skurichina</surname> <given-names>M</given-names>
</name>
<name>
<surname>Duin</surname> <given-names>RPW</given-names>
</name>
</person-group>. <article-title>Bagging, Boosting and the Random Subspace Method for Linear Classifiers</article-title>. <source>Pattern Anal Appl</source> (<year>2002</year>) <volume>5</volume>(<issue>2</issue>):<page-range>121&#x2013;35</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s100440200011</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freund</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Schapire</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>A Desicion-Theoretic Generalization of On-Line Learning and an Application to Boosting</article-title>. <source>J Comput Syst Sci</source> (<year>1997</year>) <volume>55</volume>:<page-range>119&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/jcss.1997.1504</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schapire</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Singer</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Improved Boosting Algorithms Using Confidence-Rated Predictions</article-title>. <source>Mach Learn</source> (<year>1999</year>) <volume>37</volume>:<fpage>297</fpage>&#x2013;<lpage>336</lpage>. doi: <pub-id pub-id-type="doi">10.1023/A:1007614523901</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schapire</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>The Boosting Approach to Machine Learning: An Overview</article-title>. <source>Nonlinear Estim Classif</source> (<year>2003</year>) <volume>171</volume>:<page-range>149&#x2013;71</page-range>. doi: <pub-id pub-id-type="doi">10.1007/978-0-387-21579-2_9</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stralen</surname> <given-names>KV</given-names>
</name>
<name>
<surname>Stel</surname> <given-names>VS</given-names>
</name>
<name>
<surname>Reitsma</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Dekker</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Zoccali</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jager</surname> <given-names>KJ</given-names>
</name>
</person-group>. <article-title>Diagnostic Methods I: Sensitivity, Specificity, and Other Measures of Accuracy</article-title>. <source>Kidney Int</source> (<year>2009</year>) <volume>75</volume>(<issue>12</issue>):<page-range>1257&#x2013;63</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ki.2009.92</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Marom</surname> <given-names>ND</given-names>
</name>
<name>
<surname>Rokach</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shmilovici</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Using the Confusion Matrix for Improving Ensemble Classifiers</article-title>. In: <source>2010 IEEE 26-th Convention of Electrical and Electronics Engineers in Israel</source>. <publisher-name>IEEE</publisher-name>.</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanley</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Mcneil</surname> <given-names>BJ</given-names>
</name>
</person-group>. <article-title>The Meaning and Use of the Area Under a Receiver Operating Characteristic (ROC) Curve</article-title>. <source>Radiology</source> (<year>1982</year>) <volume>143</volume>(<issue>1</issue>):<fpage>29</fpage>. doi: <pub-id pub-id-type="doi">10.1148/radiology.143.1.7063747</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curchoe</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Bormann</surname> <given-names>CL</given-names>
</name>
</person-group>. <article-title>Artificial Intelligence and Machine Learning for Human Reproduction and Embryology Presented at ASRM and ESHRE 2018</article-title>. <source>J Assist Reprod Genet</source> (<year>2019</year>) <volume>36</volume>:<fpage>591</fpage>&#x2013;<lpage>600</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10815-019-01408-x</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bormann</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Kanakasabapathy</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Thirumalaraju</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>R</given-names>
</name>
<name>
<surname>Pooniwala</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kandula</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Performance of a Deep Learning Based Neural Network in the Selection of Human Blastocysts for Implantation</article-title>. <source>Elife</source> (<year>2020</year>) <volume>9</volume>:<fpage>e55301</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.55301</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xi</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Individualized Embryo Selection Strategy Developed by Stacking Machine Learning Model for Better <italic>In Vitro</italic> Fertilization Outcomes: An Application Study</article-title>. <source>Reprod Biol Endocrinol</source> (<year>2021</year>) <volume>19</volume>(<issue>1</issue>):<fpage>53</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12958-021-00734-z</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunderson</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Puga Molina</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Spies</surname> <given-names>N</given-names>
</name>
<name>
<surname>Balestrini</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Buffone</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Jungheim</surname> <given-names>ES</given-names>
</name>
<etal/>
</person-group>. <article-title>Machine-Learning Algorithm Incorporating Capacitated Sperm Intracellular pH Predicts Conventional <italic>In Vitro</italic> Fertilization Success in Normospermic Patients</article-title>. <source>Fertil Steril</source> (<year>2021</year>) <volume>115</volume>(<issue>4</issue>):<page-range>930&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fertnstert.2020.10.038</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blank</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wildeboer</surname> <given-names>RR</given-names>
</name>
<name>
<surname>DeCroo</surname> <given-names>I</given-names>
</name>
<name>
<surname>Tilleman</surname> <given-names>K</given-names>
</name>
<name>
<surname>Weyers</surname> <given-names>B</given-names>
</name>
<name>
<surname>de Sutter</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Prediction of Implantation After Blastocyst Transfer in <italic>In Vitro</italic> Fertilization: A Machine-Learning Perspective</article-title>. <source>Fertil Steril</source> (<year>2019</year>) <volume>111</volume>(<issue>2</issue>):<page-range>318&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fertnstert.2018.10.030</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sunkara</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Rittenberg</surname> <given-names>V</given-names>
</name>
<name>
<surname>Raine-Fenning</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zamora</surname> <given-names>J</given-names>
</name>
<name>
<surname>Coomarasamy</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Association Between the Number of Eggs and Live Birth in IVF Treatment: An Analysis of 400 135 Treatment Cycles</article-title>. <source>Hum Reprod</source> (<year>2011</year>) <volume>26</volume>(<issue>7</issue>):<page-range>1768&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/der106</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLernon</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Steyerberg</surname> <given-names>EW</given-names>
</name>
<name>
<surname>Te Velde</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Predicting the Chances of a Live Birth After One or More Complete Cycles of <italic>In Vitro</italic> Fertilisation: Population Based Study of Linked Cycle Data From 113 873 Women</article-title>. <source>BMJ</source> (<year>2016</year>) <volume>355</volume>:<elocation-id>i5735</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.i5735</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mascarenhas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mehlawat</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kirubakaran</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bhandari</surname> <given-names>H</given-names>
</name>
<name>
<surname>Choudhary</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Live Birth and Perinatal Outcomes Using Cryopreserved Oocytes: An Analysis of the Human Fertilisation and Embryology Authority Database From 2000 to 2016 Using Three Clinical Models</article-title>. <source>Hum Reprod</source> (<year>2021</year>) <volume>36</volume>(<issue>5</issue>):<page-range>1416&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/deaa343</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>